Showing 1,641 - 1,660 results of 27,423 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 5 ((teer decrease) OR (nn decrease)) ))', query time: 0.77s Refine Results
  1. 1641
  2. 1642
  3. 1643

    Summary of the gradual disappearance of the peaks with decreasing DMSO-d6 concentrations. by Swagata Chakraborty (188090)

    Published 2012
    “…<p>(<b>A</b>) <sup>1</sup>H-<sup>15</sup>N HSQC spectra of GED in 100%, 90%, 85%, 80%, 70% and 50% DMSO-d6 at 45°C, as marked in the left hand panel within the spectra. …”
  4. 1644
  5. 1645
  6. 1646
  7. 1647
  8. 1648
  9. 1649
  10. 1650
  11. 1651
  12. 1652

    Decreased spacing with different numbers of branches to enhance green fig production by Rafael Pio (4618255)

    Published 2023
    “…The spacing of 0.50 m decreases production per plant, but increases yield in 73%. …”
  13. 1653

    Brivanib decreases viability of PDGF-BB treated LX-2 cells. by Ikuo Nakamura (548298)

    Published 2014
    “…Cells showed a brivanib dose-dependent decrease in viability, with half maximal inhibitory concentration (IC<sub>50</sub>) of 16.98 µM (95% CI 13.95 µM–20.67 µM). …”
  14. 1654
  15. 1655

    Supplementary Material for: Decreases in Brain Size and Encephalization in Anatomically Modern Humans by Stibel J.M. (11623042)

    Published 2021
    “…Growth in human brain size and encephalization is well documented throughout much of prehistory and believed to be responsible for increasing cognitive faculties. Over the past 50,000 years, however, both body size and brain mass have decreased but little is known about the scaling relationship between the two. …”
  16. 1656
  17. 1657
  18. 1658

    3‑Hydroxyquinolin-2-Ones Act as Dual Inhibitors of Ferroptosis and Monoamine Oxidase B: Reducing Alzheimer’s Disease-Related Amyloid Precursor Protein and Hyperphosphorylated Tau I... by Yangjing Lv (21580685)

    Published 2025
    “…Additionally, overexpression of monoamine oxidase B (MAO-B) induces oxidative stress and decreases cognitive function. In this study, we presented the novel dual inhibitors of ferroptosis and MAO-B for AD management, aiming to address both the symptomatic and neurodegenerative aspects of this disease. …”
  19. 1659
  20. 1660